CoChat

The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.

Comparative study of available medical therapy for hypercalcemia of malignancy

Mundy, Gregory R., Wilkinson, Robert, Heath, David A. · 1983 · The American Journal of Medicine

Abstract

The relative efficacy of five drugs in the treatment of hypercalcemia of malignancy was assessed in a randomized study. The drugs were oral phosphate, mithramycin, glucocorticoids, indomethacin, and ethane-1-hydroxy-1, 1-diphosphonate (EHDP). No single agent was universally effective. Oral phosphate and mithramycin were the most efficacious, each producing a decrease in serum calcium concentrations in four of five patients, although there were serious disadvantages with the use of each. Glucocorticoids were effective in only two of five patients who received randomized treatment. A further five patients received nonrandomized treatment with glucocorticoids, and only three of these showed response. Indomethacin was effective in only one of five patients to whom it was given, and EHDP was effective also in only one of five patients. The new diphosphonate, 3-amino-1-hydroxypropane-1, 1-diphosphonate (APD) was evaluated in the treatment of hypercalcemia in 13 patients with malignant disease and two with primary hyperparathyroidism. APD caused a significant decrease in serum calcium concentration in nine of 12 patients within 72 hours. These results indicate that there is no currently available pharmacologic agent that is entirely satisfactory in the treatment of hypercalcemia. The most effective agents were mithramycin, oral phosphate, and APD. Glucocorticoids and orally administered EHDP showed limited effectiveness, and indomethacin was ineffective in the majority of patients.

Overview

Integrity signals

Registry

Crossref · 10.1016/0002-9343(83)90961-0

Cites

26 of 26 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 26 references

Research works printed but not linked: 2

  1. Kantrowitz, 1975, Clinical and biochemical effects of diphosphonate in Paget's disease of bone (abstr), Arthritis Rheum, 18, 407A
  2. 1978, Editorial: Management of hypercalcaemic crisis, Lancet, II, 617

Cited by

See all 163

Metadata

Authors
Mundy, G. R., Wilkinson, R., & Heath, D. A.
Corresponding author
Mundy, Gregory R.
Venue
The American Journal of Medicine
Publisher
Elsevier BV
Published
1983-03
Volume
74
Issue
3
Pages
421-432
ISSN
0002-9343 (ISSN-L)
OpenAlex
W2054887634
Cited by
163
References
26
Citations by year
2021: 1 · 2020: 1 · 2018: 1 · 2015: 2 · 2013: 1 · 2012: 1
FWCI
6.93
Type
journal article
Language
en
Open access
closed
Licence
  • www.elsevier.com/tdm/userlicense/1.0/ (tdm)
  • www.elsevier.com/legal/tdmrep-license (tdm)
Locations
  • The American Journal of Medicine (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Oncology › Bone health and treatments
  • Health Sciences › Medicine › Nephrology › Parathyroid Disorders and Treatments
  • Health Sciences › Medicine › Surgery › Management of metastatic bone disease
Keywords
hypercalcemia of malignancy, hypercalcemia treatment, mithramycin, glucocorticoids, indomethacin, ethane-1-hydroxy-1,1-diphosphonate, bisphosphonates, primary hyperparathyroidism
MeSH terms
Pamidronate, Administration, Oral, Adult, Aged, Calcium, Clinical Trials as Topic, Diphosphonates, Female, Glucocorticoids, Humans, Hypercalcemia, Hyperparathyroidism, Indomethacin, Male, Middle Aged, Plicamycin, Neoplasms, Phosphates, Random Allocation, Etidronic Acid, Time Factors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Comparative study of available medical therapy for hypercalcemia of malignancy. https://app.cochat.ai/papers/10.1016/0002-9343(83)90961-0
The paper
Mundy, G. R., Wilkinson, R., & Heath, D. A. (1983). Comparative study of available medical therapy for hypercalcemia of malignancy. The American Journal of Medicine. https://doi.org/10.1016/0002-9343(83)90961-0

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.